3 Ways Ketamine Reduces Inflammation to Help Joint Pain, Arthritis, and Chronic Pain

how ketamine reduces inflammation and chronic pain

Chronic pain is often associated with, and/or related to, persistent inflammation. Inflammatory processes involve the activation and recruitment of immune cells, as well as the production of cytokines—proteins that mediate and regulate inflammation. Elevated levels of proinflammatory cytokines can exacerbate pain and contribute to the persistence of chronic pain conditions – and ketamine has shown to reduce these inflammatory cytokines.

Ketamine’s Mechanism of Action in Reducing Inflammation

Ketamine’s ability to reduce inflammation is linked to its complex mechanism of action, which involves modulating the glutamatergic system and influencing various inflammatory pathways.

Key research findings have shown that ketamine can:

  1. Reduce Proinflammatory Cytokines: A randomized, double-blind, placebo-controlled study demonstrated that ketamine significantly decreases levels of proinflammatory cytokines, including IL-1beta, TNF-alpha, IFN-gamma, and GM-CSF (Nikkheslat et al., 2021).

  2. Modulate the Kynurenine Pathway: Ketamine indirectly reduces inflammation through its effects on the kynurenine pathway, which is involved in both inflammatory processes and neurotransmitter production (Jóźwiak-Bębenista et al., 2023).

  3. Influence Inflammatory Cell Recruitment: Ketamine impacts the recruitment of inflammatory cells, potentially reducing the overall inflammatory response (S. et al., 2011).


What Ketamine Does in the Body Physically & Biologically to Reduce Inflammation & Pain

Reduces Cytokines: Cytokines are signaling molecules that play a crucial role in the body’s immune response. Proinflammatory cytokines, such as IL-1beta, TNF-alpha, IFN-gamma, and GM-CSF, are known to contribute to inflammation and pain. By reducing the levels of these cytokines, ketamine can help alleviate inflammation and, consequently, reduce pain.

Modulates the Kynurenine Pathway: The kynurenine pathway is involved in the metabolism of tryptophan, an essential amino acid. This pathway produces metabolites that can influence both inflammation and neurotransmission. Ketamine’s modulation of the kynurenine pathway helps decrease the production of proinflammatory metabolites, thereby reducing inflammation and its associated symptoms.

Impacts Inflammatory Cell Recruitment: Inflammatory cells, such as macrophages and neutrophils, are recruited to sites of injury or infection to help combat pathogens and initiate tissue repair. However, excessive recruitment and activation of these cells can lead to chronic inflammation and pain. Ketamine’s ability to influence the recruitment of inflammatory cells can help mitigate this excessive response, promoting a more balanced immune reaction

Ketamine’s Clinical Implications for Chronic Pain, Inflammation, and Pain Management

Ketamine’s anti-inflammatory properties offer a promising approach for managing chronic pain conditions. By targeting the underlying inflammatory processes, ketamine can provide relief for patients suffering from conditions such as:

  • Rheumatoid arthritis
  • Fibromyalgia
  • Complex regional pain syndrome (CRPS)
  • Neuropathic pain

 

Further, one of the significant advantages of ketamine is its rapid onset of action. Unlike traditional anti-inflammatory medications, which can take days or weeks to show effects, ketamine can provide quick relief from inflammation and pain. This rapid action is particularly beneficial for patients experiencing severe pain or flare-ups of chronic conditions.

Ketamine’s ability to reduce inflammation and alleviate chronic pain represents a significant advancement in pain management. By modulating inflammatory pathways, reducing proinflammatory cytokines, and influencing inflammatory cell recruitment, ketamine offers a multifaceted approach to treating chronic pain conditions. As research continues, ketamine’s role in managing inflammation and pain will likely expand, providing new hope for patients with chronic inflammatory conditions.

For anyone considering ketamine as a treatment option, it is essential to consult with healthcare professionals to ensure it is administered safely and effectively. 

Nushama is dedicated to providing evidence-based treatments and personalized care to help patients achieve optimal health and well-being. Learn more today.

Nushama

Discover What Psychedelic Medicine Can Do for You

To transcend depression, anxiety, alcohol use disorders, and trauma-induced mood disorders, Nushama offers IV ketamine for an ego-dissolving psychedelic experience. A holistic path of mindful intention setting, ketamine journeys, and thoughtful integration in safe, healing-focused settings empower members to reset and reconnect.

Explore Our Blog